Ohcanbohtosat - G. Chenuc

Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study Dahkki Suzette Delaloge, David Pérol, Coralie Courtinard, Étienne Brain, Bernard Asselain, Thomas Bachelot, Marc Debled, Véronique Dièras, Mario Campone, Christelle Lévy, William Jacot, Véronique Lorgis, Corinne Veyret, Florence Dalenc, Jean‐Marc Ferrero, L. Uwer, Pierre Kerbrat, Anthony Gonçalvès, Marie‐Ange Mouret‐Reynier, Thierry Petit, Christelle Jouannaud, Laurence Vanlemmens, G. Chenuc, T. Guesmia, Mathieu Robain, C. Cailliot